Literature DB >> 26318389

Uric acid and coronary artery disease: An elusive link deserving further attention.

Simone Biscaglia1, Claudio Ceconi2, Michele Malagù1, Rita Pavasini1, Roberto Ferrari3.   

Abstract

Uric acid is the final product of purine metabolism. Classically it is recognized as the cause of gouty arthritis and kidney stones. Western civilization has increased serum levels of uric acid which is no longer considered a benign plasma solute. It has been postulated and recently demonstrated that it can penetrate cell membrane and exerts damaging intracellular actions such as oxidation and inflammation. These observations have stimulated several epidemiological researches suggesting that hyperuricemia is linked or even provokes hypertension and coronary artery disease. In this review we summarize the current evidences regarding uric acid which contribute in the pathophysiology of coronary artery disease.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CAD; Reactive oxygen species; Uric acid

Mesh：

Substances：

Year:  2015        PMID： 26318389     DOI： 10.1016/j.ijcard.2015.08.086

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


  24 in total

1.  Hyperuricemia and severity of coronary artery disease: An observational study in adults 35 years of age and younger with acute coronary syndrome.

Authors:  Sai Lv; Wei Liu; Yujie Zhou; Yuyang Liu; Dongmei Shi; Yingxin Zhao; Xiaoli Liu; Jumana W Alhelal; K S Shakeenah Ravuru
Journal:  Cardiol J       Date:  2018-03-07       Impact factor: 2.737

2.  Analysis of traditional and emerging risk factors in premenopausal women with coronary artery disease: A pilot-scale study from North India.

Authors:  Rajesh Vijayvergiya; Divya Kapoor; Ajay Aggarwal; Sonal Sangwan; Vanita Suri; Veena Dhawan
Journal:  Mol Cell Biochem       Date:  2017-03-23       Impact factor: 3.396

3.  The validity, stability, and utility of measuring uric acid in saliva.

Authors:  Jenna L Riis; Crystal I Bryce; Marla J Matin; John L Stebbins; Olga Kornienko; Lauren van Huisstede; Douglas A Granger
Journal:  Biomark Med       Date:  2018-06-06       Impact factor: 2.851

Review 4.  The effect of allopurinol on cardiovascular outcomes in patients with type 2 diabetes: a systematic review.

Authors:  Evanthia Bletsa; Stavroula A Paschou; Vasiliki Tsigkou; Panagiota K Stampouloglou; Vasiliki Vasileiou; Georgia N Kassi; Evangelos Oikonomou; Gerasimos Siasos
Journal:  Hormones (Athens)       Date:  2022-10-05       Impact factor: 3.419

Review 5.  Hyperuricemia: a novel old disorder-relationship and potential mechanisms in heart failure.

Authors:  Claudio Borghi; Alberto Palazzuoli; Matteo Landolfo; Eugenio Cosentino
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

6.  Serum Uric Acid Could Differentiate Acute Myocardial Infarction and Unstable Angina Pectoris in Hyperuricemic Acute Coronary Syndrome Patients.

Authors:  Sabaheta Hasic; Damira Kadic; Emina Kiseljakovic; Radivoj Jadric; Emina Spahic
Journal:  Med Arch       Date:  2017-04

Review 7.  Uric Acid for Cardiovascular Risk: Dr. Jekyll or Mr. Hide?

Authors:  Cristina Vassalle; Annamaria Mazzone; Laura Sabatino; Clara Carpeggiani
Journal:  Diseases       Date:  2016-02-26

8.  Serum uric acid is associated with incidence of heart failure with preserved ejection fraction and cardiovascular events in patients with arterial hypertension.

Authors:  Jun Gu; Yu-Qi Fan; Hui-Li Zhang; Jun-Feng Zhang; Chang-Qian Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-15       Impact factor: 3.738

9.  The Association Between Hyperuricemia and Hematological Indicators in a Chinese Adult Population.

Authors:  Pu Su; Liu Hong; Yifan Zhao; Hang Sun; Liang Li
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

10.  Evaluation of the Effectiveness of Xanthine Oxidoreductase Inhibitors on Haemodialysis Patients using a Marginal Structural Model.

Authors:  Takeo Ishii; Masataka Taguri; Kouichi Tamura; Kunio Oyama
Journal:  Sci Rep       Date:  2017-10-25       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.